AMIODARONE VERSUS LIDOCAINE FOR PEDIATRIC CARDIAC ARREST DUE TO VENTRICULAR ARRHYTHMIAS: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i7.1748Keywords:
lidocaine, amiodarone, cardiac arrestAbstract
Background: Pediatric cardiac arrests are relatively uncommon but pose significant burdens. The management of pediatric cardiac arrest is unclear between amiodarone or lidocaine, necessitating further research to establish effective interventions.
Aim: to systematically review the effect and funtion of amiodarone and lidocaine, whether amiodarone is more recommended or vice versa.
Methods: this review conducted a thorough literature search comparing amiodarone and lidocaine for shock-refractory pVT/VF in children. Outcomes, including ROSC, termination of arrhythmia, and survival at discharge, were also evaluated.
Results: Out of 756 articles, only three met inclusion criteria comparing amiodarone and lidocaine for VT/VF. One adult study favored amiodarone for survival to hospital admission, but not discharge. Another study on pediatric cases showed lidocaine improved ROSC and 24-hour survival significantly. However, evidence quality was very low for both drugs, warranting further research. A small trial in adults favored amiodarone in stable VT, but its limited size and data quality pose limitations.
Conclusion: The findings of this systematic review proposes that either amiodarone or lidocaine could be considered for the treatment of pediatric shock-resistant VF/pVT.
References
1. Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, et al. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests. Circulation. 2013;127(4):442–51.
2. Donoghue AJ, Abella BS, Merchant R, Praestgaard A, Topjian A, Berg R, et al. Cardiopulmonary resuscitation for in-hospital events in the emergency department: A comparison of adult and pediatric outcomes and care processes. Resuscitation [Internet]. 2015;92:94–100. Tersedia pada: http://dx.doi.org/10.1016/j.resuscitation.2015.04.027
3. De Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, et al. Part 12: Pediatric Advanced Life Support 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care (Reprint). Pediatrics. 2015;136(through 2012):S176–95.
4. Perry JC, Fenrich AL, Hulse JE, Triedman JK, Friedman RA, Lamberti JJ. Pediatric use of intravenous amiodarone: Efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996;27(5):1246–50.
5. Hamilton D, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C, et al. Amiodarone: A Comprehensive Guide for Clinicians. Am J Cardiovasc Drugs [Internet]. 2020;20(6):549–58. Tersedia pada: https://doi.org/10.1007/s40256-020-00401-5
6. Karnina R, Arif SK, Hatta M, Bukhari A. Molecular mechanisms of lidocaine. Ann Med Surg [Internet]. 2021;69(August):102733. Tersedia pada: https://doi.org/10.1016/j.amsu.2021.102733
7. Valdes SO, Donoghue AJ, Hoyme DB, Hammond R, Berg MD, Berg RA, et al. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. Resuscitation [Internet]. 2014;85(3):381–6. Tersedia pada: http://dx.doi.org/10.1016/j.resuscitation.2013.12.008
8. Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, et al. Intravenous Lidocaine versus intravenous Amiodarone (in a New Aqueous Formulation) for incessant ventricular tachycardia. Am J Cardiol. 2012;90(8):853–9.
9. As A, With C, For L, Fibrillation SV. FOR SHOCK-RESISTANT VENTRICULAR FIBRILLATION A M I O DA R O N E V E R S U S L I D O C A I N E F O R S H O C K- R E S I STA N T V E N T R I C U L A R F I B R I L L AT I O N. 2012;346(12):884–90.
10. Morrison LJ, Gent LM, Lang E, Nunnally ME, Parker MJ, Callaway CW, et al. Part 2: Evidence evaluation and management of conflicts of interest: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18):S368–82.
11. Holmberg MJ, Ross CE, Atkins DL, Valdes SO, Donnino MW, Andersen LW, et al. Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: An observational study. Resuscitation. 2020;149(December 2019):191–201.
12. Callans DJ, Gottlieb CD, Marchlinski FE. zt. 2017;830–43.
13. Tijssen J, DeCaen A. No shocking updates for the lidocaine vs amiodarone in pediatric pVT/VF story. Resuscitation [Internet]. 2020;149:233–4. Tersedia pada: https://doi.org/10.1016/j.resuscitation.2020.02.012
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
